Revive Therapeutics Ltd (RVVTF)

[tripmcneely]

What scenarios can play out here soon:

1. End point change denied. Game over

2. End point change approved. MF then prepares for submission for unblinding of data to DMSB?

3. More information and discussion needed on pending end point request? Delay continues while revive scrambles yet again?

4. End point change approved and unblinded data show’s positive efficacy allowing unblinding of all data and quick submission to FDA.

Any other possible scenario im missing?